Oxycodone

Nazia M. Sadiq, Travis J. Dice, Therese Mead, Nazia M. Sadiq, Travis J. Dice, Therese Mead

Excerpt

Oxycodone is a potent opioid that can be useful when used judiciously for pain. However, it can cause physical dependence and addiction. The immediate-release formulation of oxycodone is FDA approved for the management of acute or chronic moderate to severe pain, for which the use of opioid medication is deemed appropriate and for which other pain management strategies are insufficient. The extended-release formulation is FDA approved for the management of pain severe enough to require continuous long-term opioid treatment and for which there are no alternative options to treat the pain. The oxycodone to morphine dose equivalent ratio is approximately 1 to 1.5 for immediate-release and 1 to 2 for extended-release formulations. This activity reviews the indications, side effects, and contraindications for oxycodone and highlights the role of the interprofessional team in helping patients manage their pain.

Conflict of interest statement

Disclosure: Nazia Sadiq declares no relevant financial relationships with ineligible companies.

Disclosure: Travis Dice declares no relevant financial relationships with ineligible companies.

Disclosure: Therese Mead declares no relevant financial relationships with ineligible companies.

Copyright © 2024, StatPearls Publishing LLC.

References

    1. Torabi R, Bourn L, Mundinger GS, Saeg F, Patterson C, Gimenez A, Wisecarver I, St Hilaire H, Stalder M, Tessler O. American Society of Plastic Surgeons Member Post-Operative Opioid Prescribing Patterns. Plast Reconstr Surg Glob Open. 2019 Mar;7(3):e2125.
    1. Kalso E. Oxycodone. J Pain Symptom Manage. 2005 May;29(5 Suppl):S47-56.
    1. Thigpen JC, Odle BL, Harirforoosh S. Opioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and Children. Eur J Drug Metab Pharmacokinet. 2019 Oct;44(5):591-609.
    1. Riley J, Eisenberg E, Müller-Schwefe G, Drewes AM, Arendt-Nielsen L. Oxycodone: a review of its use in the management of pain. Curr Med Res Opin. 2008 Jan;24(1):175-92.
    1. Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S3-13.
    1. Lugo RA, Kern SE. The pharmacokinetics of oxycodone. J Pain Palliat Care Pharmacother. 2004;18(4):17-30.
    1. Kinnunen M, Piirainen P, Kokki H, Lammi P, Kokki M. Updated Clinical Pharmacokinetics and Pharmacodynamics of Oxycodone. Clin Pharmacokinet. 2019 Jun;58(6):705-725.
    1. Drugs and Lactation Database (LactMed®) [Internet] National Institute of Child Health and Human Development; Bethesda (MD): 2023. Dec 15, Oxycodone.
    1. Sachs HC, Committee On Drugs The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics. 2013 Sep;132(3):e796-809.
    1. van Dorp E, Yassen A, Dahan A. Naloxone treatment in opioid addiction: the risks and benefits. Expert Opin Drug Saf. 2007 Mar;6(2):125-32.
    1. Remillard D, Kaye AD, McAnally H. Oxycodone's Unparalleled Addictive Potential: Is it Time for a Moratorium? Curr Pain Headache Rep. 2019 Feb 28;23(2):15.
    1. Leppert W, Zajaczkowska R, Wordliczek J. The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation. Expert Opin Pharmacother. 2019 Apr;20(5):511-522.
    1. Kiyatkin EA. Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl. Neuropharmacology. 2019 Jun;151:219-226.
    1. Kummer O, Hammann F, Moser C, Schaller O, Drewe J, Krähenbühl S. Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. Eur J Clin Pharmacol. 2011 Jan;67(1):63-71.
    1. Rauck RL. Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies. Pain Pract. 2019 Apr;19(4):443-454.
    1. Freedman-Weiss MR, Chiu AS, Solomon DG, Christison-Lagay ER, Ozgediz DE, Cowles RA, Caty MG, Stitelman DH. Opioid Prescribing Habits of General Versus Pediatric Surgeons After Uncomplicated Laparoscopic Appendectomy. J Surg Res. 2019 Mar;235:404-409.
    1. Concheiro M, Chesser R, Pardi J, Cooper G. Postmortem Toxicology of New Synthetic Opioids. Front Pharmacol. 2018;9:1210.
    1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet] National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda (MD): 2020. Nov 24, Oxycodone.
    1. Piper BJ, Desrosiers CE, Fisher HC, McCall KL, Nichols SD. A New Tool to Tackle the Opioid Epidemic: Description, Utility, and Results from the Maine Diversion Alert Program. Pharmacotherapy. 2017 Jul;37(7):791-798.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe